BREAKING: Tech Futures Jump On Megacap Earnings Diabetes playÂ Dexcom (DXCM), featured in today's IBD 50 Stocks To Watch, continues to show strength after wrapping up an eight-week holding period.A 22% return on equity last year is above the 17% minimum desired of leading growth stocks and helps the company earn an A SMR Rating (sales + profit margins + ROE).